CRYSTAL ADAM (President, R&D) sold 18.9% of their position (27K shares) of TANGO THERAPEUTICS, INC. on the open market
Open‑market sale worth $660.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/5/2026ACC: 0001193125-26-414500
Officer· President, R&D
Since Feb 2026
-27K
Net shares
Net seller
$660.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
27K acquired · 54K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+27K
Price / share
$5.20
Trade value
$140.40K
% of position
23.3%
10/1/2026
115.74K→142.74K
Common Stock
Direct
Shares
−26.40K
Price / share
$24.45
Trade value
$645.60K
% of position
18.5%
10/1/2026
142.74K→116.34K
Common Stock
Direct
Shares
−600.00
Price / share
$25.32
Trade value
$15.19K
% of position
0.5%
10/1/2026
116.34K→115.74K
Total
Net shares
+0.00
Net value
-$520.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | M · Option Exercise | +27K | $5.20 | $140.40K | 23.3% | 115.74K | 142.74K |
| Common Stock Direct | 10/1/2026 | S · Sale | −26.40K | $24.45 | $645.60K | 18.5% | 142.74K | 116.34K |
| Common Stock Direct | 10/1/2026 | S · Sale | −600.00 | $25.32 | $15.19K | 0.5% | 116.34K | 115.74K |
| Total | +0.00 | -$520.40K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
27K shares
Shares
−27K
Strike price
5.2
Held after
233.04K
Exercisable
—
10/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 10/1/2026 | M · Option Exercise | −27K | 5.2 | — | 233.04K |